Khaled Fareed, M.D.

Khaled Fareed, MD, is a Staff Member in the Department of Regional Urology at the Glickman Urological and Kidney Institute. His specialty interests include robotic nerve sparing prostatectomy, laparoscopic partial and radical nephrectomy, BPH minimally invasive procedures including Green Light laser and kidney stone surgeries.

Dr. Fareed earned his medical degree from Assiut University School of Medicine in Egypt. He completed an internship and residency in urology and general surgery at University of Texas Southwestern Medical center at Dallas, Texas. Dr. Fareed is licensed by the State Medical Board of Ohio.

He is a member of several professional societies, including the American Urological Association, Endourological Society, European Association of Urology, American Medical Association and the American Association of Clinical Urologists, among others.

He has published a number of articles and abstracts on topics such as MRI characteristics and laparoscopic radiofrequency of renal lesions, laparoscopic urological surgery, and overactive bladder in men, among many others. He has also lectured on bladder cancer and prostate cancer detection.

Robotic nerve sparing prostatectomy, laparoscopic partial and radical nephrectomy, BPH minimally invasive procedures including Green Light laser and kidney stone surgeries.

• American Urological Association
• European Association of Urology
• American Medical Association
• Endourological Society

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 10/24/2008 the review process regarding Dr. Fareed’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)